Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | NSE - Pharmaceuticals


INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.

 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
4,655
5,222
6,540
6,472
7,231
Cash flow Operating Act...
Cash flow Operating Activities
2,3604,7283,9944,9055,779
Investments in PPE
Investments in PPE
-3,044-4,034-2,913-1,559-442
Cash flow Investing Act...
Net cash used for Investment Activities
3,008-1,042-1,433-5684,186
Dividend Paid
Dividend Paid
4,2352,5412,9654,0856,776
Cash flow Financing Act...
Net cash provided by Financing Activities
-5,108-3,066-3,584-4,276-6,961
Cash at beginning of period
Cash at beginning of period
1,1491,3912,0119881,048
Cash at end of period
Cash at end of period
1,4092,0119881,0484,052
Free Cash Flow
Free Cash Flow
-684
694
1,081
3,346
5,337